Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply Comment uri icon

Overview

MeSH Major

  • Antiviral Agents
  • Hepatitis C, Chronic
  • Interferon-alpha
  • Polyethylene Glycols
  • Ribavirin

publication date

  • September 2013

Research

keywords

  • Comment

Identity

Digital Object Identifier (DOI)

  • 10.1111/apt.12424

PubMed ID

  • 23937463

Additional Document Info

start page

  • 554

end page

  • 5

volume

  • 38

number

  • 5